Page 355

World Rugby Handbook

REGULATION 21 shall be considered negative and the Player, the Player’s Union, National Anti-Doping Organisation and WADA shall be so informed. 21.7.4.4 If that review does not reveal an applicable TUE or a departure from the International Standard for Testing and Investigations or the International Standard for Laboratories and/or historical test data that caused the Atypical Finding and/or explains the Atypical Finding as arising from a permitted source, World Rugby shall conduct the required investigation or cause it to be conducted. This investigation may involve without limitation the requirement of the Player to undergo medical testing to ascertain the presence or otherwise of a pathological or other medical explanation for the Atypical Finding. After the investigation is completed, either the Atypical Finding will be brought forward as an Adverse Analytical Finding, in accordance with Regulation 21.7.3.1, or else the Player, the Player’s Union, National Anti-Doping Organisation and WADA shall be notified that the Atypical Finding will not be brought forward as an Adverse Analytical Finding. 21.7.4.5 World Rugby will not provide notice of an Atypical Finding until it has completed its investigation and has decided whether it will bring the Atypical Finding forward as an Adverse Analytical Finding unless one of the following circumstances exists: 21.7.4.5.1 If World Rugby determines the B Sample should be analysed prior to the conclusion of its investigation, it may conduct the B Sample analysis after notifying the Player, with such notice to include a description of the Atypical Finding and the information described in Regulation 21.7.3.1(d)- (f). 21.7.4.5.2 If World Rugby is asked (a) by a Major Event Organisation shortly before one of its International Events, or (b) by a sport organisation responsible for meeting an imminent deadline for selecting team members for an International Event, to disclose whether any Player identified on a list provided by the Major Event Organisation or sport organisation has a pending Atypical Finding, World Rugby shall so advise the Major Event Organisation or sports organisation after first providing notice of the Atypical Finding to the Player. 21.7.4.5.3 World Rugby's investigation requires the Player to undergo medical testing to ascertain the presence or otherwise of a pathological explanation for the Atypical Finding. 21.7.5 Review of Atypical Passport Findings and Adverse Passport Findings Review of Atypical Passport Findings and Adverse Passport Findings shall take place as provided in the International Standard for Testing and Investigations and International Standard for Laboratories. At such time as World Rugby is satisfied that an anti-doping rule violation has occurred, it shall promptly give the Player (and simultaneously the Player’s Union, National Anti-Doping Organisation and WADA) notice of the anti-doping rule violation asserted and the basis of that assertion. Last update: 14 January, 2015 355


World Rugby Handbook
To see the actual publication please follow the link above